0001493152-24-000154.txt : 20240102 0001493152-24-000154.hdr.sgml : 20240102 20240102190849 ACCESSION NUMBER: 0001493152-24-000154 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231229 FILED AS OF DATE: 20240102 DATE AS OF CHANGE: 20240102 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jayasuriya Anula CENTRAL INDEX KEY: 0001822933 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12830 FILM NUMBER: 24503982 MAIL ADDRESS: STREET 1: 5150 EL CAMINO REAL, SUITE #A-32 CITY: LOS ALTOS STATE: CA ZIP: 94022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Lineage Cell Therapeutics, Inc. CENTRAL INDEX KEY: 0000876343 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 943127919 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 BUSINESS PHONE: 5105213390 MAIL ADDRESS: STREET 1: 2173 SALK AVENUE STREET 2: SUITE 200 CITY: CARLSBAD STATE: CA ZIP: 92008 FORMER COMPANY: FORMER CONFORMED NAME: BIOTIME INC DATE OF NAME CHANGE: 19930328 4 1 ownership.xml X0508 4 2023-12-29 0 0000876343 Lineage Cell Therapeutics, Inc. LCTX 0001822933 Jayasuriya Anula 2173 SALK AVENUE, SUITE 200 CARLSBAD CA 92008 1 0 0 0 0 Common Shares, no par value 2023-12-29 4 P 0 10000 1.09 A 10000 D The price reported is a weighted average. The shares were purchased in multiple transactions at prices ranging from not less than $1.08 to not more than $1.09. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range. Does not include common shares that may be acquired upon the exercise of stock options outstanding as of the date of this report. /s/ Alexandra Hernandez, as Attorney-in Fact 2024-01-02